⚠️ “These Pills Can Cause Blood Clots…” — Which Ones?
This headline is too vague to identify a specific medicine. Several different types of tablets can increase the risk of blood clots, and the risk varies substantially by drug and by the person taking it.
One well-established example is the JAK-inhibitor class. The FDA requires boxed warnings for:
- Tofacitinib (Xeljanz/Xeljanz XR)
- Baricitinib (Olumiant)
- Upadacitinib (Rinvoq)
These medicines are used for certain inflammatory diseases. FDA warnings include increased risks of blood clots, heart attack, stroke and death in certain patients. The risk is particularly important in people with cardiovascular risk factors or who currently or previously smoked. (U.S. Food and Drug Administration)
Another example is systemic estrogen therapy, which can increase the risk of blood clots and stroke and has important contraindications. (U.S. Food and Drug Administration)
🚨 Don’t stop a prescribed medicine because of a viral headline
If you’re taking a medication mentioned in an article like this, don’t stop it abruptly without speaking with your doctor or pharmacist. The benefits may outweigh the risks for you, and alternatives may not be appropriate.
Seek emergency help for possible clot or cardiovascular symptoms such as new chest pressure, significant shortness of breath, coughing blood, or sudden swelling/pain in one leg. (U.S. Food and Drug Administration)
If you send me the full article, link, or the names of the pills in the headline, I can check each medication against current official safety information and tell you which claims are accurate.
